Clin2
NCT05247112Worth exploringRecruiting

Tracking antibiotic resistance in H. pylori infections in Korea

Helicobacter Pylori InfectionHelicobacter Pylori Associated Gastrointestinal DiseaseHelicobacter Pylori Infection, Susceptibility toHelicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation

Part of Digestive system, Infections clinical trials.

This study looks at how resistant H. pylori (a stomach germ) is to different antibiotics in Korea. It uses stomach endoscopy samples to test which antibiotics may or may not work, helping guide future treatment choices.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
Any age
Study type
Observational

Who can take part

  • You must have a confirmed H. pylori infection.
  • You must agree to undergo an endoscopy and provide a sample for lab testing.
  • Your sample will be used to measure how sensitive H. pylori is to antibiotics (minimum inhibitory concentration).
  • You should not be pregnant or breastfeeding.
  • You should not have taken antibiotics, proton pump inhibitors (acid blockers), or bismuth salts in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05561504Recruiting
Study of stomach bacteria resistance in adults

This study looks at how common a stomach bacteria infection is and which antibiotics still work. You may help researchers by providing consent for related study participation and sample tracking.

Munich
NCT06200779Not yet recruiting· Phase 4
Tailored vs. standard treatment for H. pylori infection

This trial compares a personalized treatment approach to the standard one for H. pylori infection. If you are scheduled for an upper endoscopy and need biopsies, you may be able to join.

Porto, Porto District
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei
NCT05061732Recruiting· Phase 4
Treatment and follow-up study for Helicobacter pylori infection

This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.

Shanghai, Shanghai Municipality
NCT05121025Recruiting
Study of stomach bacteria and gut microbes in Helicobacter infection

This study looks at how stomach bacteria (Helicobacter pylori) interact with the normal microbes in your gut. You may be asked to provide tissue, stool, and blood samples to help researchers understand infection and the body’s response.

Freiburg im Breisgau, Baden-Wurttemberg
NCT07516262Recruiting
How Stomach Acid Medication Affects H. Pylori Detection

This study looks at whether a common stomach acid medication (PPIs) affects the accuracy of a stool test for detecting H. pylori, a bacteria that can cause ulcers and stomach inflammation. Understanding this helps doctors know when the stool test works best.

Shanghai, Shanghai Municipality

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.